Stocks · Health care · Services-Commercial Physical & Biological Research

Incyte

INCY Clue Score71

United States Fiscal year ends December CIK 0000879169 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net buying

By person

39 insiders · 401 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Baker Bros. Advisors LP entity

Director

$299.55M (40)

—

+$299.55M

28,520,360

14.07%

$3.39B

−8.5%

Herve Hoppenot

Director

$1.91M (2)

$50.85M (6) scheduled

−$48.93M

326,803

0.1612%

$38.88M

−14.4%

Steven H Stein

CMO & Head of Late-Stage Dev.

—

$28.29M (35) scheduled

−$28.29M

30,916

0.0153%

$3.68M

+56.8%

Paul A Friedman

Director

—

$24.72M (6) scheduled

−$24.72M

256,813

0.1267%

$30.55M

−9.1%

Paula J Swain

EVP, Human Resources

—

$20.37M (27) scheduled

−$20.37M

106,482

0.0525%

$12.67M

+264.1%

Pablo J Cagnoni

President, Global Head of R&D

—

$14.40M (10) scheduled

−$14.40M

183,200

0.0904%

$21.79M

+1,016%

Barry P Flannelly

EVP & General Manager US

—

$13.81M (33) scheduled

−$13.81M

35,149

0.0173%

$4.18M

+143.6%

Yao Wenqing

EVP, Head of Discovery Chem

—

$13.63M (13) scheduled

−$13.63M

98,575

0.0486%

$11.73M

−28.6%

Maria E Pasquale

EVP & General Counsel

—

$9.67M (17) scheduled

−$9.67M

69,724

0.0344%

$8.29M

+7,554%

David W Gryska

Executive Vice President, CFO

—

$9.18M (8) scheduled

−$9.18M

10,235

0.0050%

$1.22M

−46.2%

Paul Trower

Principal Accounting Officer

—

$8.64M (17) scheduled

−$8.64M

32,268

0.0159%

$3.84M

+151.7%

Vijay K Iyengar

EVP, Gmapps

—

$8.24M (25) scheduled

−$8.24M

40,540

0.0200%

$4.82M

+401.1%

Michael James Morrissey

EVP, Head of Tech. Operations

—

$7.30M (4) scheduled

−$7.30M

34,065

0.0168%

$4.05M

−20.9%

Patrick A Mayes

EVP & Chief Scientific Officer

—

$6.56M (15) scheduled

−$6.56M

61,441

0.0303%

$7.31M

−8.8%

Wendy L Dixon

Director

—

$6.37M (6) scheduled

−$6.37M

17,768

0.0088%

$2.11M

+107.8%

Reid M Huber

EVP, Chief Scientific Officer

—

$3.15M (6)

−$3.15M

34,571

0.0171%

$4.11M

−49.9%

Paul A Brooke

Director

—

$2.96M (1) scheduled

−$2.96M

261,911

0.1292%

$31.16M

+33.3%

Sheila A. Denton

EVP & General Counsel

—

$2.14M (16) scheduled

−$2.14M

26,569

0.0131%

$3.16M

+3,950%

Jonathan Elliott Dickinson

EVP, General Manager, Europe

—

$2.02M (4)

−$2.02M

36,390

0.0180%

$4.33M

+36.1%

Dashyant Dhanak

EVP & Chief Scientific Officer

—

$1.87M (20) scheduled

−$1.87M

58,968

0.0291%

$7.01M

—

Eric H. Siegel

EVP, General Counsel

—

$1.75M (7) scheduled

−$1.75M

21,053

0.0104%

$2.50M

+43.0%

Thomas Tray

Principal Accounting Officer

—

$1.58M (18) scheduled

−$1.58M

21,126

0.0104%

$2.51M

+19.4%

Paul J Clancy

Director

—

$1.42M (1) scheduled

−$1.42M

25,838

0.0127%

$3.07M

—

Mohamed Khairie Issa

EVP, Head of U.S. Commercial

—

$1.31M (2) scheduled

−$1.31M

71,797

0.0354%

$8.54M

—

Jean Jacques Bienaime

Director

$533.44K (7)

$212.89K (3)

+$320.55K

24,424

0.0120%

$2.91M

+2,540%

Lee Heeson

EVP, Head of Incyte Intl

—

$289.02K (1) scheduled

−$289.02K

37,578

0.0185%

$4.47M

—

Julian Baker

Director

—

—

—

767,095

0.3784%

$91.25M

—

William Meury

Chief Executive Officer

—

—

—

183,129

0.0903%

$21.79M

—

Christiana Stamoulis

EVP & Chief Financial Officer

—

—

—

125,759

0.0620%

$14.96M

+6,346%

Suketu Upadhyay

EVP & Chief Financial Officer

—

—

—

26,343

0.0130%

$3.13M

—

Edmund Harrigan

Director

—

—

—

23,225

0.0115%

$2.76M

—

Jacqualyn A Fouse

Director

—

—

—

20,968

0.0103%

$2.49M

—

Richard A. Hoffman

EVP & General Counsel

—

—

—

16,861

0.0083%

$2.01M

—

David H Gardner

EVP, Chief Strategy Officer

—

—

—

15,904

0.0078%

$1.89M

—

Katherine A High

Director

—

—

—

14,983

0.0074%

$1.78M

—

Matteo Trotta

EVP, GM, Dermatology US

—

—

—

14,882

0.0073%

$1.77M

+3,593%

Otis W Brawley

Director

—

—

—

12,894

0.0064%

$1.53M

—

Ramitpal K Basi

EVP, Human Resources

—

—

—

10,993

0.0054%

$1.31M

—

Susanne Schaffert

Director

—

—

—

7,389

0.0036%

$879.00K

—